Understanding Overactive Bladder: Symptoms, Assessment and Treatment Options

/2 Comments/in , , /by

Overactive bladder can make everyday life feel organised around the nearest toilet. Shopping, travelling, exercise, sleep and social activities may all be affected by sudden urgency, frequent urination or leakage.

It is common, but it is not simply an inevitable part of ageing. Symptoms deserve assessment because several bladder, urinary and medical conditions can produce a similar pattern.

This article explains overactive bladder as a condition and outlines the broad approaches used to investigate and manage it. It does not recommend a particular medicine, device or brand.

What is overactive bladder?

Overactive bladder (OAB) is a symptom syndrome characterised by urinary urgency, a sudden, compelling need to pass urine that is difficult to defer. It is usually accompanied by increased frequency during the day and waking at night to urinate, with or without urgency urinary incontinence.

Possible symptoms include:

  • a sudden need to urinate that is difficult to postpone
  • passing urine more frequently than expected
  • waking repeatedly at night to urinate
  • leaking urine before reaching the toilet
  • restricting travel or activities because of toilet access
  • using pads because of unpredictable urgency

OAB is a clinical diagnosis. Some people demonstrate involuntary bladder contractions, known as detrusor overactivity, during urodynamic testing; others with typical symptoms do not.

What causes the symptoms?

The bladder normally stores urine at low pressure and empties when it is convenient. OAB symptoms arise when the sensation or control of bladder filling becomes abnormal. The cause is not always identifiable.

Factors that can cause or aggravate similar symptoms include:

  • urinary tract infection
  • excessive caffeine, alcohol or fluid intake
  • medicines such as diuretics
  • constipation
  • poorly controlled diabetes
  • bladder stones
  • incomplete bladder emptying
  • bladder outlet obstruction
  • pelvic floor dysfunction
  • genitourinary syndrome of menopause
  • neurological conditions
  • reduced mobility or difficulty reaching a toilet
  • sleep disorders or fluid redistribution causing nocturia

Visible blood in the urine, recurrent infection, pelvic pain, difficulty passing urine or rapidly changing symptoms require further assessment rather than an assumption that OAB is the cause.

Overactive bladder in men

Urgency and frequency in men may occur alone or together with bladder outlet obstruction from prostate enlargement, urethral narrowing or impaired bladder contraction.

An assessment may therefore include the urinary stream, prostate, urinary flow and the amount of urine remaining after voiding. Treating urgency without recognising significant obstruction or incomplete emptying may worsen retention in some patients.

Overactive bladder after menopause

After menopause, reduced oestrogen can contribute to vaginal dryness, irritation, recurrent urinary infection, urgency and discomfort. These changes are often grouped under the term genitourinary syndrome of menopause.

Identifying vaginal or urinary tract changes is important because management may differ from treatment for isolated OAB. Any hormonal treatment requires an individual discussion of suitability, expected benefit, uncertainty and risk.

How is OAB assessed?

Assessment begins with listening to the pattern and impact of the symptoms. Depending on the individual, it may include:

  • a medical, urinary and medication history
  • examination
  • urinalysis or urine culture
  • a bladder diary
  • review of fluid, caffeine and alcohol intake
  • assessment of bowel function
  • measurement of urinary flow
  • ultrasound measurement of post-void residual urine
  • kidney-function or glucose testing when clinically indicated
  • assessment for pelvic organ prolapse or prostate enlargement

A bladder diary records the timing and volume of drinks, urination, urgency and leakage. It can help distinguish OAB from excessive urine production, nocturnal polyuria or habitual frequent voiding.

Are urodynamic studies always required?

No. Many patients with uncomplicated symptoms can begin conservative treatment without urodynamics.

Urodynamic testing may be helpful when the diagnosis is uncertain, bladder emptying is poor, previous treatment has failed, neurological dysfunction is suspected, or an invasive treatment is being considered. The test should answer a specific clinical question rather than be performed routinely.

When might cystoscopy or imaging be needed?

Cystoscopy or urinary tract imaging is not automatically required for uncomplicated OAB. It may be considered when there is blood in the urine, recurrent infection, pain, suspected stones, previous pelvic surgery, obstruction or another concerning feature.

First steps in management

Conservative treatment is often the starting point and may be used alone or with other therapies.

Bladder training

Bladder training aims to increase the interval between toilet visits and reduce the habit of urinating “just in case.” A planned program may involve:

  • recording voiding patterns
  • gradually extending the interval between voids
  • using distraction, breathing or pelvic floor contractions when urgency occurs
  • avoiding rushing to the toilet where it is safe to pause

Progress is usually gradual. An unrealistic schedule can lead to frustration or increased leakage.

Pelvic floor rehabilitation

Pelvic floor exercises may help suppress urgency and improve continence. Correct technique matters; repeatedly contracting the wrong muscles or performing excessive exercises may be unhelpful. Assessment by a pelvic floor physiotherapist can be useful.

Fluids and bladder irritants

Reducing excessive caffeine or alcohol may improve symptoms. Large volumes of fluid over a short period can also provoke urgency.

Fluid should not be restricted excessively. Concentrated urine may irritate the bladder and inadequate intake can contribute to constipation, infection or dehydration. Advice should reflect medical conditions, climate and activity.

Constipation, weight and mobility

Treating constipation may reduce pressure on the bladder. Weight reduction can improve urinary symptoms for some people. Mobility aids, clear access to the toilet and suitable clothing can reduce functional leakage even when bladder symptoms persist.

Managing nocturia

Waking at night to urinate is not always caused by OAB. Other contributors include sleep apnoea, leg swelling, heart or kidney disease, evening fluid intake and medicines.

Management should be directed at the cause. Moving a diuretic to a different time, for example, should occur only on advice from the prescribing clinician.

Where do prescription medicines fit?

Prescription medicines may be discussed when conservative measures have not provided sufficient relief, when symptoms are particularly troublesome, or when a combined approach is appropriate.

Two broad medicine classes are commonly used:

  1. Antimuscarinic medicines, which reduce muscarinic stimulation of the bladder.
  2. Beta-3 adrenergic agonists, which promote bladder relaxation during filling.

These medicines are not suitable for everyone. The choice should follow an individual assessment of symptoms, bladder emptying, other medical conditions, current medicines and personal priorities.

Antimuscarinic medicines

This class may reduce urgency, frequency and urgency incontinence in some patients. Possible adverse effects include:

  • dry mouth
  • constipation
  • blurred vision or dry eyes
  • dizziness or drowsiness
  • difficulty emptying the bladder
  • urinary retention
  • confusion or cognitive effects, particularly in susceptible older people

Caution may be required in people with impaired bladder emptying, certain forms of glaucoma, severe constipation or gastrointestinal motility disorders, cognitive impairment, or a high total anticholinergic burden.

Anticholinergic burden and cognition

Many medicines used for conditions other than OAB also have anticholinergic effects. The combined burden may contribute to dry mouth, constipation, sedation, falls, confusion and loss of function.

Observational research has found associations between prolonged exposure to medicines with strong anticholinergic effects and cognitive decline or dementia. An association does not prove that a particular medicine caused dementia in an individual patient, but the overall medication burden deserves review—especially in older people or those with cognitive concerns.

Beta-3 adrenergic agonists

This class acts differently and generally produces fewer classic anticholinergic effects. Possible adverse effects can include:

  • increased blood pressure
  • headache
  • palpitations or faster heart rate
  • urinary tract infection
  • difficulty emptying the bladder
  • medicine interactions

Blood pressure, cardiovascular history, kidney or liver function, bladder emptying and interacting medicines may influence suitability. Current Australian Product Information should guide prescribing and monitoring.

Can medicine classes be combined?

Combination therapy may be considered after a partial response to a single medicine, but additional benefit must be weighed against increased adverse effects, interactions and cost.

In men with both storage symptoms and possible bladder outlet obstruction, treatment may also need to address the obstructive component. A urinary flow test and post-void residual measurement may help guide the decision.

How is a medicine trial reviewed?

A medicine trial should have a clear purpose and review point. Reassessment may consider:

  • urgency episodes
  • daytime and night-time frequency
  • leakage and pad use
  • bladder diary findings
  • quality of life
  • blood pressure where relevant
  • constipation, dry mouth, cognition or other adverse effects
  • urinary flow and residual urine in patients at risk of retention

If there is little benefit or unacceptable harm, the diagnosis and management plan should be reconsidered. Increasing or continuing treatment indefinitely is not automatically appropriate.

Patients should not start, stop or change a prescription medicine without advice from their prescriber.

What if conservative care and medicines are insufficient?

Persistent symptoms do not mean that no further options exist. Reassessment is important before an invasive treatment to confirm the likely cause and identify incomplete emptying, obstruction or another condition.

Depending on the patient, options may include:

Intravesical botulinum toxin treatment

A prescription medicine can be injected into the bladder wall through a cystoscope to reduce involuntary bladder contractions. Some patients experience reduced urgency and leakage, but benefit varies and is temporary.

Important risks include urinary tract infection, increased residual urine and inability to empty the bladder adequately. Some patients require temporary intermittent self-catheterisation. Treatment must be selected and administered by an appropriately qualified clinician.

Tibial nerve stimulation

Electrical stimulation near the ankle can influence the nerve pathways involved in bladder control. Treatment protocols vary, and repeated sessions may be required. Response is variable.

Sacral neuromodulation

Sacral neuromodulation uses an implanted system to stimulate nerves involved in bladder and pelvic-floor control. It may be considered for selected patients after assessment and usually involves a test phase. Potential disadvantages include an operation, device-related complications, later revision and ongoing follow-up.

These treatments differ in invasiveness, risks, durability, repeat-treatment requirements, availability and cost. None is the best choice for every patient.

When should medical advice be sought promptly?

Prompt assessment is appropriate for:

  • inability to pass urine
  • visible blood in the urine
  • fever, flank pain or systemic illness with urinary symptoms
  • recurrent urinary infections
  • new leg weakness, numbness or loss of bowel control
  • significant pelvic or bladder pain
  • rapidly worsening symptoms
  • new incontinence accompanied by neurological symptoms

Urgent or emergency care may be required when symptoms are severe.

Questions to discuss with a clinician

  • Are my symptoms most consistent with OAB, or could there be another cause?
  • Am I emptying my bladder adequately?
  • Which conservative measures are most relevant to me?
  • What are the reasonable treatment options, including no immediate treatment?
  • What benefit might I realistically expect?
  • Which adverse effects or interactions matter with my other conditions and medicines?
  • How and when will treatment be reviewed?
  • Would further testing change management?
  • What symptoms should prompt urgent assessment?

The bottom line

Overactive bladder is a symptom syndrome, not a single test result. Assessment should look for infection, excessive urine production, incomplete emptying, obstruction, menopause-related changes, neurological disease and other contributors.

Management usually begins with education, bladder training, pelvic floor rehabilitation and attention to fluids, caffeine, constipation and related medical problems. Prescription medicine may be one part of treatment after an individual assessment, but benefits vary and adverse effects matter.

When symptoms remain troublesome, further evaluation and carefully selected minimally invasive treatments may be considered. The aim is not simply to prescribe another tablet; it is to understand the cause, reduce symptoms safely and improve daily life.

This article provides general disease education and does not replace individual medical advice. It does not promote or recommend a particular prescription medicine, therapeutic product, device or brand. Treatment decisions should be made with an appropriately qualified health professional after assessment of the individual patient.

References and further reading

Publication note

This draft is structured as general disease education for an Australian public-facing website. It should not be accompanied by branded medicine or device imagery, product pricing, supply information, testimonials, inducements, superiority claims, or wording that encourages a reader to request a named therapeutic good. Review the page title, search metadata, images, links, social-media caption and nearby booking prompts together, because the overall context determines whether material may be regarded as advertising.

Pelvic Floor Rehabilitation Before and After Prostate Surgery

/0 Comments/in , /by

Preparing the Pelvic Floor for Recovery

Urinary leakage is one of the most common concerns men have when preparing for prostate surgery, particularly radical prostatectomy for prostate cancer. Fortunately, urinary control usually improves progressively after surgery, and pelvic floor rehabilitation can play an important role in helping men regain continence.

Pelvic floor rehabilitation is more than simply “doing Kegels”. It involves learning which muscles to use, how to contract them correctly, when to relax them, and how to incorporate them into everyday activities.

Importantly, more exercise is not necessarily better. The aim is a pelvic floor that is strong, coordinated and responsive, rather than one that is constantly clenched.

What Is the Male Pelvic Floor?

The pelvic floor is a group of muscles forming a supportive sling beneath the pelvis. These muscles contribute to:

  • urinary continence;
  • bowel control;
  • support of the pelvic organs;
  • sexual function; and
  • control of pressure generated during coughing, lifting and physical activity.

After radical prostatectomy, the anatomy of the urinary continence mechanism changes. The prostate and prostatic urethra are removed and the bladder is reconnected to the remaining urethra. Urinary control consequently becomes more dependent upon the remaining urinary sphincter and its supporting pelvic floor musculature.

This is why pelvic floor rehabilitation is particularly relevant after prostate cancer surgery.

Why Start Pelvic Floor Rehabilitation Before Surgery?

Ideally, pelvic floor rehabilitation begins before the operation.

The principal advantage of pre-operative training is not necessarily building dramatically stronger muscles. Rather, it gives the patient an opportunity to identify and correctly activate the pelvic floor before surgery, when there is no catheter, discomfort or postoperative urinary leakage.

Evidence regarding whether pre-operative pelvic floor muscle training independently improves long-term continence rates is mixed. Current European guidelines conclude that pre-operative training has not consistently demonstrated an additional long-term benefit. However, pelvic floor muscle training after radical prostatectomy may shorten the time taken to recover continence.

For many patients, a consultation with a physiotherapist experienced in men’s pelvic health before surgery is therefore useful.

Finding the Correct Pelvic Floor Muscles

A pelvic floor contraction should feel as though you are trying to:

stop yourself passing wind while simultaneously shortening or drawing the penis slightly inward and lifting the scrotum.

The movement should be subtle.

During the contraction:

  • continue breathing normally;
  • avoid holding your breath;
  • keep the abdomen relatively relaxed;
  • avoid strongly squeezing the buttocks;
  • avoid excessive tightening of the thighs; and
  • completely relax the pelvic floor between contractions.

Some men find the correct muscles immediately. Others inadvertently brace their abdominal, buttock or thigh muscles.

This is one reason why an assessment by a pelvic floor physiotherapist can be valuable.

Should I stop my urine flow to find the muscles?

Stopping the urinary stream once can sometimes help identify the muscles involved, but repeatedly practising pelvic floor exercises by interrupting urination is generally not recommended.

Regularly stopping and starting the stream can interfere with normal bladder emptying.

A Practical Pelvic Floor Exercise Programme

There is no single exercise prescription that is perfect for every man. Pelvic floor strength, endurance, coordination and postoperative continence vary considerably.

A physiotherapist may therefore modify the programme according to your examination and progress.

A typical programme contains several components.

1. Slow contractions: strength and endurance

Gently contract and lift the pelvic floor.

Hold the contraction for approximately:

5–10 seconds

Then relax completely for approximately:

5–10 seconds

Repeat approximately:

8–10 times

The quality of the contraction is more important than achieving a particular number.

If you can only maintain a good contraction for three seconds initially, three good seconds are preferable to ten seconds of straining.

2. Quick contractions

The urinary sphincter also needs to react rapidly.

Contract the pelvic floor firmly for approximately one second, then completely release it.

Repeat:

5–10 times

These faster contractions help train the pelvic floor to respond to sudden increases in abdominal pressure.

3. The “Knack”

One of the most useful techniques is learning to contract the pelvic floor immediately before an activity that normally produces leakage.

For example, gently activate the pelvic floor just before:

  • coughing;
  • sneezing;
  • standing from a chair;
  • bending;
  • lifting;
  • getting out of a car; or
  • performing physical exercise.

This anticipatory contraction is sometimes called the Knack.

It turns pelvic floor training from an isolated exercise into a functional skill.

How Often Should I Exercise?

This is where the principle of quality rather than quantity becomes important.

For many men, a structured programme performed two to three times per day is sufficient during active rehabilitation.

A session might consist of:

8–10 controlled slow contractions followed by 5–10 quick contractions.

However, this should not be regarded as a universal prescription. Your physiotherapist or surgeon may recommend a different programme according to your muscle strength, continence and ability to relax the pelvic floor.

The pelvic floor is skeletal muscle. Like other muscles, it needs work, recovery and progression.

Doing hundreds of contractions every day is rarely necessary.

Can You Do Too Many Pelvic Floor Exercises?

Yes.

One of the common misconceptions after prostate surgery is:

“If ten exercises are good, one hundred must be better.”

Unfortunately, pelvic floor muscles can become fatigued just like any other muscle.

Excessive training or constantly holding the pelvic floor contracted can potentially cause:

  • pelvic or perineal discomfort;
  • difficulty relaxing the pelvic floor;
  • urinary urgency;
  • difficulty starting urination;
  • interrupted urinary flow;
  • a sensation of incomplete bladder emptying;
  • pelvic muscle fatigue; and
  • occasionally worsening leakage later in the day as the muscles tire.

A healthy pelvic floor needs to be able to contract strongly and relax completely.

Continence does not require walking around all day with the pelvic floor permanently switched on.

How Do I Know When I Am Doing Enough?

Your programme is probably adequate when you can:

  • identify the pelvic floor reliably;
  • contract it without excessive abdominal or buttock activity;
  • maintain several controlled contractions without losing strength;
  • completely relax between contractions;
  • activate the muscles quickly before coughing or lifting; and
  • progressively incorporate pelvic floor control into normal activities.

Progress after prostatectomy is often better measured by continence rather than the number of exercises performed.

Useful measures include:

  • number of pads used each day;
  • degree of pad wetness;
  • a 24-hour pad-weight test;
  • leakage during walking or exercise;
  • ability to remain dry overnight;
  • ability to reach the toilet without leakage; and
  • changes over several weeks rather than from one day to the next.

When Should Exercises Restart After Surgery?

Follow the instructions given by your surgeon.

Pelvic floor contractions are usually stopped while the urinary catheter is in place.

Training can generally recommence after catheter removal once your surgical team considers it appropriate. European guidance notes that pelvic floor muscle training is commonly started approximately 7–10 days after catheter removal, although individual postoperative protocols vary.

Early exercises should be gentle.

This is not the time to test how hard you can squeeze.

As healing progresses, the programme can gradually move from basic contractions to functional training while standing, walking, coughing, lifting and exercising.

What Should I Expect After the Catheter Comes Out?

The first few days can be confronting.

Some men have relatively little leakage immediately. Others experience considerable leakage, particularly when:

  • standing;
  • walking;
  • coughing;
  • exercising;
  • getting out of a chair; or
  • becoming tired later in the day.

This does not necessarily predict the final outcome.

Continence often improves substantially during the first weeks and months following radical prostatectomy.

Recovery is a marathon measured in millilitres rather than kilometres.

How Successful Is Pelvic Floor Physiotherapy?

This question is more complicated than it initially appears.

Urinary continence frequently improves naturally following prostatectomy, making it difficult for studies to separate the effect of pelvic floor physiotherapy from normal postoperative recovery.

The research is consequently mixed.

The European Association of Urology notes that systematic reviews and trials suggest pelvic floor muscle training can shorten the time to continence recovery, although the evidence regarding supervised training, biofeedback and additional therapies remains inconsistent.

For example, one randomised study cited by the EAU compared supervised physiotherapist-directed pelvic floor training with verbal and written instructions. At 12 months, complete pad-free continence was reported in 65.2% of the supervised group versus 31.6% of the comparison group. This result should not be interpreted as the expected success rate for every patient, because continence definitions, surgical techniques and rehabilitation programmes differ considerably between studies.

A 2023 Cochrane review was considerably more cautious. After reviewing 25 trials, the authors concluded that uncertainty remains regarding the magnitude of benefit from conservative treatments because studies vary considerably in their techniques, combinations of treatments and methodological quality.

The practical message is therefore:

Pelvic floor rehabilitation is an important first-line treatment and may accelerate recovery, but it cannot guarantee continence.

What If Pelvic Floor Exercises Are Not Working?

Persistent leakage does not automatically mean you need to exercise harder.

If continence is failing to improve, the first question should be:

Why am I leaking?

Post-prostatectomy urinary incontinence may result from:

  • weakness of the urinary sphincter;
  • bladder overactivity;
  • urinary urgency;
  • incomplete bladder emptying;
  • bladder-neck or urethral narrowing;
  • a combination of stress and urgency incontinence; or
  • less commonly, other urinary tract problems.

The AUA guideline emphasises distinguishing stress incontinence, where leakage occurs with coughing, walking, lifting or exertion, from urgency incontinence, where leakage accompanies a sudden compelling desire to urinate.

No amount of extra squeezing will correct every one of these problems.

When Should Further Investigation Be Considered?

Further assessment may be appropriate when urinary leakage is:

  • severe;
  • worsening rather than improving;
  • associated with difficulty urinating;
  • associated with significant urgency or frequency;
  • persistent despite appropriate rehabilitation; or
  • sufficiently troublesome that surgical treatment is being considered.

Assessment may include:

Bladder diary

Records fluid intake, urinary frequency, urinary volumes and leakage episodes.

Pad-weight testing

Provides an objective measurement of the amount of urine being lost.

Urinary flow measurement and bladder ultrasound

Can identify poor urinary flow or incomplete bladder emptying.

Cystoscopy

May be recommended when urethral or bladder-neck pathology is suspected.

Urodynamic studies

Can sometimes help distinguish sphincter weakness from bladder dysfunction when the cause of persistent leakage is uncertain or before further treatment.

What Alternatives Are Available if Physiotherapy Is Not Enough?

Pelvic floor rehabilitation is only one part of managing post-prostatectomy incontinence.

Lifestyle and bladder strategies

These may include:

  • appropriate fluid intake;
  • reducing excessive caffeine;
  • avoiding constipation;
  • weight management where appropriate;
  • bladder training;
  • management of urinary urgency; and
  • modifying activities that provoke significant leakage during early recovery.

Continence pads

Modern male continence pads provide discreet protection while continence is recovering.

Using pads does not mean rehabilitation has failed. They are simply a tool for allowing normal activity during recovery.

Penile compression devices

A penile clamp can temporarily reduce leakage in selected men, although these devices must be fitted and used correctly and released regularly to avoid excessive pressure or tissue injury.

Medication

Medication does not generally correct true post-prostatectomy sphincter weakness.

However, medication may be useful when overactive bladder or urinary urgency contributes significantly to leakage.

Biofeedback

Biofeedback can help some patients understand whether they are contracting the correct muscles and how effectively they are doing so.

Electrical stimulation

Electrical stimulation has also been investigated. Some studies suggest an early benefit when combined with pelvic floor training, although evidence remains inconsistent.

When Is Surgery Considered?

A small proportion of men continue to experience significant stress urinary incontinence despite adequate healing and rehabilitation.

If the leakage remains bothersome, further treatment should be discussed rather than simply continuing increasingly intensive pelvic floor exercises indefinitely.

The two principal surgical options are:

Male Sling

A male sling supports and repositions the urethral continence mechanism.

It is generally most suitable for selected men with mild to moderate stress urinary incontinence and adequate residual sphincter function.

Results tend to be less favourable when incontinence is severe. The AUA guideline specifically notes that male sling outcomes are poorer in men with severe sphincteric incontinence.

Artificial Urinary Sphincter

The artificial urinary sphincter (AUS) remains an important treatment for moderate to severe post-prostatectomy stress urinary incontinence.

A fluid-filled cuff is placed around the urethra and controlled by a small pump positioned within the scrotum. The patient operates the pump when he wishes to urinate.

Both male sling surgery and artificial urinary sphincter implantation can significantly reduce pad use and improve quality of life in appropriately selected men.

When Should I Stop Pelvic Floor Rehabilitation?

There is rarely a precise finishing date.

Once continence has returned and pelvic floor control is good, intensive rehabilitation can usually be reduced.

Many men transition from a rehabilitation programme to a simple maintenance programme, incorporating occasional pelvic floor exercises and functional contractions during activities that generate abdominal pressure.

If you are completely dry, have good pelvic floor control and can cough, lift and exercise without leakage, performing increasingly large numbers of exercises is unlikely to provide additional benefit.

The goal is not to become a professional Kegel athlete.

The goal is normal function.

The Bottom Line

Pelvic floor rehabilitation is an important component of recovery following radical prostatectomy.

Learning the technique before surgery can make it easier to identify and activate the correct muscles after the catheter is removed. Following surgery, a structured programme focusing on strength, endurance, rapid contractions, relaxation and functional activation may help accelerate the return of urinary control. Current evidence supports pelvic floor muscle training as part of postoperative management, while acknowledging that the precise additional benefit of intensive supervised physiotherapy remains uncertain.

Just as importantly, more is not always better. Persistent leakage should not automatically be treated with ever-increasing numbers of pelvic floor contractions.

If urinary incontinence remains troublesome despite appropriate rehabilitation, further assessment can determine whether the problem is persistent sphincter weakness, bladder dysfunction or another cause. Treatments ranging from bladder therapy and medication to a male sling or artificial urinary sphincter can then be considered.

A useful rule

Train the pelvic floor, don’t exhaust it.

Correct technique, consistency and functional control matter far more than the number of contractions performed.

This information is intended for general patient education and does not replace individual medical advice. The timing and intensity of pelvic floor rehabilitation should be discussed with your surgeon and/or a physiotherapist experienced in male pelvic health.

Mid-Urethral Slings for Stress Urinary Incontinence: What Is the Current Australian Position?

/0 Comments/in , , /by

Patient information for Australian women | Reviewed 22 September 2026

The word “mesh” can understandably cause concern. Public discussion has often grouped together several very different products and operations. A mid-urethral sling used to treat female stress urinary incontinence is not the same operation as transvaginal mesh used to repair pelvic organ prolapse, and it is also different from a single-incision mini-sling.

The Urological Society of Australia and New Zealand (USANZ) supports the continued availability of mid-urethral slings in Australia as one treatment option for appropriately selected women. That support is not unconditional: USANZ emphasises appropriate clinical governance, surgeon credentialing, informed consent, multidisciplinary review where appropriate, and monitoring of patient outcomes.

What is stress urinary incontinence?

Stress urinary incontinence, or SUI, is leakage caused by an increase in abdominal pressure, for example when coughing, sneezing, laughing, exercising or lifting. It is different from urge incontinence, in which leakage is associated with a sudden compelling need to pass urine.

An accurate diagnosis matters. Some women have both stress and urgency symptoms, difficulty emptying the bladder, prolapse, recurrent infections or previous pelvic surgery. A consultation may therefore include a history, examination, bladder diary, urine testing, measurement of residual urine and, in selected or complex cases, urodynamic studies or cystoscopy.

What is a mid-urethral sling?

A mid-urethral sling is a narrow strip of permanent synthetic polypropylene mesh placed beneath the middle part of the urethra. It provides support during coughing, exercise and other activities that raise abdominal pressure.

The two established approaches are:

  • Retropubic sling: the tape passes behind the pubic bone.
  • Transobturator sling: the tape passes through the obturator region towards the groin.

These approaches have different risk profiles. The retropubic route has a greater risk of bladder perforation and short-term voiding difficulty, while the transobturator route has a greater association with groin or thigh pain. The most appropriate approach depends on the woman’s anatomy, previous operations, clinical circumstances and preferences.

What does USANZ say?

USANZ states that mid-urethral slings have an established evidence base for relative safety and effectiveness and should remain available in Australia for the treatment of female SUI. In its 2023 statement, USANZ specifically linked continued use to the clinical-governance improvements introduced in Australia since 2018, including:

  • appropriate surgeon credentialing
  • careful patient selection
  • discussion through multidisciplinary processes where indicated
  • genuine informed consent
  • monitoring of outcomes through the Australasian Pelvic Floor Procedure Registry.

This position supports patient choice, not routine surgery for every woman. Conservative care should usually be considered first, and non-mesh alternatives must be discussed when surgery is being considered.

What is the TGA position?

The Therapeutic Goods Administration (TGA) regulates medical devices in Australia. Surgical mesh is classified as a Class III medical device, the highest-risk classification, requiring more stringent evidence and regulatory assessment.

Following its safety reviews, the TGA removed certain transvaginal prolapse mesh products and single-incision mini-slings from routine supply. This did not amount to a ban on established retropubic and transobturator mid-urethral slings for SUI. The TGA’s current register includes eligible Class III urogynaecological mesh devices intended for SUI; the precise indication must always be checked in the device’s approved Instructions for Use.

The TGA requires manufacturers to provide patient information leaflets and implant cards for these devices. A woman receiving a sling should know the product used and should retain her implant card.

How effective is a mid-urethral sling?

Mid-urethral sling surgery is one of the most extensively studied operations for female SUI. Australian safety and quality guidance describes it as highly effective in the short and medium term, with long-term studies showing sustained patient satisfaction for many women.

No operation can guarantee a cure. Outcomes depend on the definition of success, length of follow-up, type of sling, surgeon experience and the individual patient. Stress leakage may persist or recur, and urgency symptoms may remain, improve or occasionally develop after surgery.

What are the risks?

Most women do not develop a serious complication, but complications can be significant and may occur early or years later. Potential risks include:

  • bleeding, infection and anaesthetic complications
  • temporary or persistent difficulty emptying the bladder, sometimes requiring catheterisation or further surgery
  • bladder or urethral injury
  • urinary tract infection
  • new or worsened urinary urgency or urge incontinence
  • persistent or recurrent stress incontinence
  • vaginal mesh exposure
  • mesh erosion into the urethra or bladder
  • pelvic, vaginal, groin or thigh pain
  • pain during intercourse
  • rarely, injury to major blood vessels, bowel or other pelvic structures.

Mesh is intended to remain permanently. If a mesh complication develops, partial or complete removal may be considered, but complete removal can be technically difficult or impossible and may require more than one operation. Removal may not fully resolve pain and can cause stress incontinence to recur.

Seek medical assessment if you develop persistent pelvic or groin pain, pain during intercourse, vaginal bleeding or discharge, recurrent urinary infections, difficulty passing urine, blood in the urine, or recurrent leakage after sling surgery.

What are the alternatives?

Treatment should be individualised. Options include:

  • no active treatment or the use of continence products
  • lifestyle measures, including weight management, treatment of constipation and chronic cough, and smoking cessation
  • supervised pelvic-floor muscle training, usually for at least three months
  • a continence pessary in suitable women
  • urethral bulking injections, which are less invasive but generally less durable and may need repeating
  • an autologous fascial sling using the patient’s own tissue
  • Burch colposuspension using sutures and native tissue.

Autologous fascial sling and colposuspension avoid permanent synthetic mesh but usually involve a longer operation and recovery and have their own risks, including voiding difficulty. There is no single best operation for every woman.

Shared decision-making and informed consent

Before proceeding, a woman should have enough time and balanced information to consider:

  • whether her symptoms are predominantly stress, urgency or mixed incontinence
  • conservative, mesh and non-mesh options
  • the expected benefits and limitations of each option
  • short- and long-term risks, including mesh-specific complications
  • the surgeon’s training and experience with the proposed procedure and alternatives
  • what follow-up will occur and how complications would be managed
  • the name and TGA registration status of the proposed device.

A second opinion is reasonable, particularly if symptoms are complex, previous continence surgery has failed, chronic pelvic pain is present, or the available options remain unclear.

The balanced Australian position

Mid-urethral slings are not appropriate for every woman, but neither are they prohibited in Australia. USANZ supports their continued availability for carefully selected patients within strong clinical-governance systems. The TGA continues to regulate eligible SUI sling devices as Class III medical devices and requires enhanced patient information and traceability.

The most important principles are an accurate diagnosis, consideration of conservative care, a balanced discussion of mesh and non-mesh alternatives, surgeon credentialing, informed consent and structured follow-up.

Important: This article provides general educational information and does not replace individual medical advice. It does not claim endorsement or approval by AHPRA, USANZ or the TGA. These organisations do not pre-approve individual practitioner website articles. Treatment recommendations must be based on personal assessment and shared decision-making.

References and further reading

  1. Urological Society of Australia and New Zealand. Vaginal mesh complications: USANZ submission, position statement and patient resources.
  2. Urological Society of Australia and New Zealand. USANZ supports pause on mesh stress urinary incontinence surgery in New Zealand. 23 August 2023.
  3. Therapeutic Goods Administration. Urogynaecological (transvaginal) surgical mesh hub. Updated 28 April 2025.
  4. Therapeutic Goods Administration. Australian transvaginal surgical mesh regulatory actions.
  5. Therapeutic Goods Administration. Current status of mesh products in Australia. Updated 9 June 2026.
  6. Australian Commission on Safety and Quality in Health Care. Treatment options for stress urinary incontinence: information for consumers. 2018.
  7. Australian Commission on Safety and Quality in Health Care. Care pathway for the management of stress urinary incontinence. 2018.
  8. Australian Health Practitioner Regulation Agency. Guidelines for advertising a regulated health service.
  9. Australian Health Practitioner Regulation Agency. Summary of the advertising requirements.